In clinical trials—where patient safety, regulatory compliance, and data quality are critical—having real-time access to reliable information makes all the difference. TrialPal, the leading ePRO/eCOA platform in vaccine studies and widely adopted in drug trials and therapies across emerging and global markets, transforms this challenge into an opportunity. With its interactive dashboards, TrialPal enables real-time monitoring, instant analysis, and informed decision-making.
A Real-Time Window Into Your Clinical Trial
TrialPal dashboards provide a comprehensive view of study progress by integrating critical information that once required multiple tools. With continuously updated key performance indicators (KPIs), users can:
- Evaluate participant symptoms and reported intensity.
- Monitor progress toward eDiary compliance.
- Visualize enrollment status, investigational product administration (vaccines or drugs), and participant dropout.
- Rapidly identify anomalies or emerging risks.
This clear and accessible visualization accelerates response to deviations and enhances coordination among clinical, operational, and medical teams.
Flexibility and Customization for Any Study
One of TrialPal’s greatest strengths is its ability to deliver on-demand, customized indicators tailored to the unique needs of each study, phase, or clinical team role.
This applies to vaccine studies (e.g., large-scale enrollment, post-vaccination safety surveillance) and drug trials (e.g., treatment adherence, long-term adverse events, compliance with scheduled visits).
Key Questions TrialPal Helps Answer in Real Time:
- How is enrollment progressing by site?
- Which symptoms or adverse events are participants reporting most frequently?
- Where is the highest risk of dropout or eDiary non-compliance?
Examples of KPIs in TrialPal Dashboards
Subject Monitoring and Compliance
- Subjects exposed to the Investigational Product (IP).
- Cumulative enrollment per day and % compliance.
- eDiary compliance (% of completed entries).
- Participant dropout rates.
eDiary Management and Reconciliation
eDiary status by project, dose, day, and date (planned vs. actual).
Reports pending, completed, reconciled, or under review.
% reconciliation compliance.
Records reconciled with clinical team comments.
Symptom and Adverse Event Tracking
Number of subjects by symptom and reported severity.
Daily distribution of local and systemic symptoms.
Changes in severity and duration during reconciliation.
Strategic Decision-Making Powered by Live Data
Data is only valuable in clinical trials if it translates into timely, actionable decisions. TrialPal ePRO/eCOA dashboards empower each role in trial operations and oversight to make informed decisions aligned with their responsibilities and with the shared objective of ensuring study quality and patient safety.
Clinical Trial Manager (CTM): Direction and Operational Efficiency
The CTM gains a strategic, real-time overview of the trial. With live KPIs, they can:
- Identify underperforming sites and adjust recruitment strategies immediately.
- Reallocate resources to areas at risk of delays.
- Detect lags in vaccination, drug administration, or follow-up visits.
- Implement corrective and preventive actions before they impact regulatory timelines or data submission.
In essence, TrialPal allows the CTM to run the study as a real-time control center, optimizing execution and ensuring protocol compliance.
Data Manager: Data Quality and Consistency
For Data Managers, TrialPal is a key ally in continuous validation. Dashboards enable them to:
- Detect and prioritize inconsistencies in symptom reporting.
- Validate data completeness before analysis cutoffs.
- Manage automated alerts for missing or duplicate critical data.
- Monitor reconciliation status for each eDiary.
This ensures that the study database meets regulatory standards and is analysis-ready—without relying on manual processes or outdated reports.
Clinical Research Associate (CRA): Smarter, Targeted Monitoring
With TrialPal, CRAs move from a reactive approach to a proactive, strategic monitoring model:
- Prioritize sites with low performance or reconciliation challenges.
- Supervise protocol adherence and eDiary compliance in real time.
- Plan efficient, targeted monitoring visits, reducing cost and time.
- Provide timely, evidence-based feedback to site teams.
This positions the CRA not just as an auditor, but as a strategic partner in study execution.
Medical Monitor: Patient Safety at the Core
For the Medical Monitor, TrialPal dashboards deliver real-time pharmacovigilance:
- Analyze symptoms and adverse events trends by frequency, intensity, and duration.
- Detect early safety signals requiring protocol or dosing adjustments.
- Recommend temporary pauses in enrollment or administration when concerning patterns arise.
- Strengthen communication with clinical and regulatory teams through consolidated, real-time data.
With TrialPal, the Medical Monitor can anticipate risks and ensure decisions always prioritize participant well-being.
Key Benefits of TrialPal Dashboards
- Rapid response to deviations in enrollment or adherence.
- Enhanced operational control without overburdening site staff.
- Improved data quality, traceability, and compliance.
- Patient safety is prioritized at every stage.
- Clinical and regulatory decisions guided by real-time evidence.
Conclusion
TrialPal redefines clinical trial monitoring by combining intuitive technology, real-time data, and clinically meaningful KPIs. Its proven success in vaccine trials positions it as a leader in emerging markets, while its flexibility makes it equally powerful for drug studies, innovative therapies, and diverse therapeutic areas.
It’s no longer just about collecting data—with TrialPal, research teams transform information into strategic decisions that ensure study success, patient safety, and operational efficiency.
